DCF — OWENSBORO HEALTH TWIN LAKES MEDICAL
Enterprise Value: $74.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$74.5M
Enterprise Value
$20.6M
PV of Cash Flows
$53.9M
PV of Terminal Value
$86.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $56.9M | $8.7M | 15.0% | $4.5M | $4.1M |
| Year 2 | $58.6M | $9.5M | 16.0% | $5.0M | $4.2M |
| Year 3 | $60.4M | $10.4M | 17.0% | $5.6M | $4.2M |
| Year 4 | $62.2M | $11.1M | 18.0% | $6.1M | $4.1M |
| Year 5 | $64.0M | $11.6M | 18.0% | $6.4M | $3.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $74.5M. Terminal value accounts for 72% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$55.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.14785117434554687
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5